# The Truth About Private Equity Consolidation: Check the Math
Private equity firms have been aggressively pursuing independent clinical practices, promising growth, operational efficiency, and expanded patient reach. For many practice owners considering these offers, the pitch sounds compelling. But Kiplinger's analysis suggests a hard look at the actual numbers before signing away your practice.
The consolidation wave has accelerated over the past five years. Private equity investors see healthcare practices as stable cash generators. They pitch standardized systems, shared administrative resources, and access to capital that independent operators cannot match alone. The narrative frames these deals as win-win. Practice owners get liquidity and reduced operational burden. Patients supposedly benefit from better technology and coordinated care.
Reality often diverges sharply from the pitch. When private equity acquires a practice, several structural changes follow. Administrative costs typically rise, not fall. PE firms layer on new management structures, reporting requirements, and compliance systems. Practices that operated lean suddenly absorb overhead that didn't exist before. Patient care timelines can stretch as PE owners prioritize profitability metrics over physician autonomy.
The math becomes problematic when you examine what happens to physician compensation and decision-making power. PE agreements typically lock in reduced autonomy. Doctors surrender hiring and firing decisions. Capital expenditures require approval from investors focused on return rates, not clinical needs. Patient loads often increase as PE operators chase volume to justify their acquisition price. Burnout accelerates.
Valuation figures merit scrutiny. PE buyers offer attractive multiples on current earnings, but those offers assume future performance levels that depend on aggressive cost-cutting or increased patient volume. If you sell at a high multiple based on optimistic projections, you're betting the practice can sustain unrealistic growth. When targets miss, your earn-out provisions shrink. You've already signed away control, so recourse becomes limited.
The exit timeline matters too. Private equity operates on defined investment horizons, typically five to seven years. That means another sale or restructuring looms before you reach traditional retirement age. You become a middle layer in someone else's exit strategy. Your successor buyer might be another PE firm, a hospital system, or a larger practice network. Each transition introduces new operational changes and fresh uncertainty.
Tax implications deserve close attention. Selling to PE may trigger substantial capital gains taxes depending on your ownership structure. Some deals structure earnout payments as ordinary income rather than capital gains. You should hire a tax advisor before any conversation advances. The difference between capital gains and ordinary income treatment can cost six figures.
Independent practice owners should demand detailed financial projections before entertaining offers. Request the PE firm's track record with similar practices. Ask for client references willing to discuss actual outcomes, not marketing testimonials. Compare proposed compensation structures against your current earnings, factoring in reduced control and increased hours often required post-acquisition.
The strongest negotiating position remains walking away. Healthy independent practices generate strong cash flow and allow physician autonomy. Those benefits have real value that standard valuation models often underestimate. A private equity check solves liquidity needs but creates new constraints.
When a PE salesperson calls with an offer, the answer should be no unless the specific numbers and terms address your actual situation, not their generic acquisition playbook.
